476
Views
17
CrossRef citations to date
0
Altmetric
Review

Recent Advances in the Clinical Value and Potential of Dexmedetomidine

, , &
Pages 7507-7527 | Published online: 30 Dec 2021

References

  • Tasbihgou SR, Barends CRM, Absalom AR. The role of dexmedetomidine in neurosurgery. Best Pract Res Clin Anaesthesiol. 2021;35(2):221–229. doi:10.1016/j.bpa.2020.10.002
  • Wang G, Niu J, Li Z, Lv H, Cai H. The efficacy and safety of dexmedetomidine in cardiac surgery patients: a systematic review and meta-analysis. PLoS One. 2018;13(9):e0202620. doi:10.1371/journal.pone.0202620
  • Constantin J-M, Momon A, Mantz J, et al. Efficacy and safety of sedation with dexmedetomidine in critical care patients: a meta-analysis of randomized controlled trials. Anaesth Crit Care Pain Med. 2016;35(1):7–15. doi:10.1016/j.accpm.2015.06.012
  • Mahmoud M, Mason KP. Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations. Br J Anaesth. 2015;115(2):171–182. doi:10.1093/bja/aev226
  • Afonso J, Reis F. Dexmedetomidine: current role in anesthesia and intensive care. Brazilian J Anesthesiol. 2012;62(1):118–133. doi:10.1016/S0034-7094(12)70110-1
  • Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine. Clin Pharmacokinet. 2017;56(8):893–913. doi:10.1007/s40262-017-0507-7
  • Ihmsen H, Saari TI. Dexmedetomidine. Anaesthesist. 2012;61(12):1059–1066. doi:10.1007/s00101-012-2114-1
  • Duan X, Coburn M, Rossaint R, Sanders RD, Waesberghe JV, Kowark A. Efficacy of perioperative dexmedetomidine on postoperative delirium: systematic review and meta-analysis with trial sequential analysis of randomised controlled trials. Br J Anaesth. 2018;121(2):384–397. doi:10.1016/j.bja.2018.04.046
  • Pan H, Liu C, Ma X, Xu Y, Zhang M, Wang Y. Perioperative dexmedetomidine reduces delirium in elderly patients after non-cardiac surgery: a systematic review and meta-analysis of randomized-controlled trials. Can J Anesth Can D’anesthésie. 2019;66(12):1489–1500. doi:10.1007/s12630-019-01440-6
  • Chamadia S, Pedemonte JC, Hobbs LE, et al. A pharmacokinetic and pharmacodynamic study of oral dexmedetomidine. Anesthesiology. 2020;133(6):1223–1233. doi:10.1097/ALN.0000000000003568
  • Su F, Gastonguay MR, Nicolson SC, DiLiberto M, Ocampo-Pelland A, Zuppa AF. Dexmedetomidine pharmacology in neonates and infants after open heart surgery. Anesth Analg. 2016;122(5):1556–1566. doi:10.1213/ANE.0000000000000869
  • Li A, Yuen VM, Goulay-Dufaÿ S, et al. Pharmacokinetic and pharmacodynamic study of intranasal and intravenous dexmedetomidine. Br J Anaesth. 2018;120(5):960–968. doi:10.1016/j.bja.2017.11.100
  • Keating GM. Dexmedetomidine: a review of its use for sedation in the intensive care setting. Drugs. 2015;75(10):1119–1130. doi:10.1007/s40265-015-0419-5
  • Turunen H, Jakob SM, Ruokonen E, et al. Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: an economic evaluation. Crit Care. 2015;19(1):67. doi:10.1186/s13054-015-0787-y
  • Jakob SM. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation. JAMA. 2012;307(11):1151. doi:10.1001/jama.2012.304
  • Xia Z-Q, Chen S-Q, Yao X, Xie C-B, Wen S-H, Liu K-X. Clinical benefits of dexmedetomidine versus propofol in adult intensive care unit patients: a meta-analysis of randomized clinical trials. J Surg Res. 2013;185(2):833–843. doi:10.1016/j.jss.2013.06.062
  • Su X, Meng Z-T, Wu X-H, et al. Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial. Lancet. 2016;388(10054):1893–1902. doi:10.1016/S0140-6736(16)30580-3
  • Cioccari L, Luethi N, Bailey M, et al. The effect of dexmedetomidine on vasopressor requirements in patients with septic shock: a subgroup analysis of the Sedation Practice in Intensive Care Evaluation [SPICE III] Trial. Crit Care. 2020;24(1):441. doi:10.1186/s13054-020-03115-x
  • Dersch-Mills DA, Banasch HL, Yusuf K, Howlett A. Dexmedetomidine use in a tertiary care NICU: a descriptive study. Ann Pharmacother. 2019;53(5):464–470. doi:10.1177/1060028018812089
  • Mondardini MC, Sperotto F, Daverio M, et al. Efficacy and safety of dexmedetomidine for prevention of withdrawal syndrome in the pediatric intensive care unit: protocol for an adaptive, multicenter, randomized, double-blind, placebo-controlled, non-profit clinical trial. Trials. 2019;20(1):710. doi:10.1186/s13063-019-3793-6
  • Wang L, Huang L, Zhang T, Peng W. Comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric dental patients under general anesthesia: a randomised clinical trial. Biomed Res Int. 2020;2020:1–7.
  • Sottas CE, Anderson BJ. Dexmedetomidine: the new all-in-one drug in paediatric anaesthesia? Curr Opin Anaesthesiol. 2017;30(4):441–451. doi:10.1097/ACO.0000000000000488
  • Mason KP, Kelhoffer ER, Prescilla R, et al. Feasibility of measuring memory response to increasing dexmedetomidine sedation in children. Br J Anaesth. 2017;118(2):254–263. doi:10.1093/bja/aew421
  • Bailey CR. Dexmedetomidine in children – when should we be using it? Anaesthesia. 2021;76(3):309–311. doi:10.1111/anae.15169
  • Mason KP, Lerman J. Dexmedetomidine in children. Anesth Analg. 2011;113(5):1129–1142. doi:10.1213/ANE.0b013e31822b8629
  • Sinha R, Kumar KR. Intravenous dexmedetomidine augments the oculocardiac reflex. J Am Assoc Pediatr Ophthalmol Strabismus. 2019;23(1):62. doi:10.1016/j.jaapos.2018.09.001
  • Shah P, Dubey K, Sahare K, Agrawal A. Intravenous dexmedetomidine versus propofol for intraoperative moderate sedation during spinal anesthesia: a comparative study. J Anaesthesiol Clin Pharmacol. 2016;32(2):245. doi:10.4103/0970-9185.168172
  • He L, Xu J-M, Liu S-M, Chen Z-J, Li X, Zhu R. Intrathecal dexmedetomidine alleviates shivering during cesarean delivery under spinal anesthesia. Biol Pharm Bull. 2017;40(2):169–173. doi:10.1248/bpb.b16-00651
  • Lamontagne C, Lesage S, Villeneuve E, Lidzborski E, Derstenfeld A, Crochetière C. Intravenous dexmedetomidine for the treatment of shivering during Cesarean delivery under neuraxial anesthesia: a randomized-controlled trial. Can J Anesth Can D’anesthésie. 2019;66(7):762–771. doi:10.1007/s12630-019-01354-3
  • Gambling DR. Intravenous dexmedetomidine. Int J Obstet Anesth. 2019;39:148. doi:10.1016/j.ijoa.2019.02.004
  • Paramasivan A, Lopez‐Olivo MA, Foong TW, Tan YW, Yap APA. Intrathecal dexmedetomidine and postoperative pain: a systematic review and meta‐analysis of randomized controlled trials. Eur J Pain. 2020;24(7):1215–1227. doi:10.1002/ejp.1575
  • Xia F, Chang X, Zhang Y, Wang L, Xiao F. The effect of intrathecal dexmedetomidine on the dose requirement of hyperbaric bupivacaine in spinal anaesthesia for caesarean section: a prospective, double-blinded, randomized study. BMC Anesthesiol. 2018;18(1):74. doi:10.1186/s12871-018-0528-2
  • Sharma A, Varghese N, Venkateswaran R. Effect of intrathecal dexmedetomidine versus intravenous dexmedetomidine on subarachnoid anesthesia with hyperbaric bupivacaine. J Anaesthesiol Clin Pharmacol. 2020;36(3):381. doi:10.4103/joacp.JOACP_323_17
  • Li BL, Zhang N, Huang JX, et al. A comparison of intranasal dexmedetomidine for sedation in children administered either by atomiser or by drops. Anaesthesia. 2016;71(5):522–528. doi:10.1111/anae.13407
  • Yuen VM, Hui TW, Irwin MG, Yao T-J, Wong GL, Yuen MK. Optimal timing for the administration of intranasal dexmedetomidine for premedication in children. Anaesthesia. 2010;65(9):922–929. doi:10.1111/j.1365-2044.2010.06453.x
  • Xie Z, Shen W, Lin J, Xiao L, Liao M, Gan X. Sedation effects of intranasal dexmedetomidine delivered as sprays versus drops on pediatric response to venous cannulation. Am J Emerg Med. 2017;35(8):1126–1130. doi:10.1016/j.ajem.2017.03.021
  • Chamadia S, Hobbs L, Marota S, et al. Oral dexmedetomidine promotes non-rapid eye movement Stage 2 sleep in humans. Anesthesiology. 2020;133(6):1234–1243. doi:10.1097/ALN.0000000000003567
  • Sajid B, Mohamed T, Jumaila M. A comparison of oral dexmedetomidine and oral midazolam as premedicants in children. J Anaesthesiol Clin Pharmacol. 2018;35(1):36–40. doi:10.4103/joacp.JOACP_20_18
  • Keles S, Kocaturk O. Comparison of oral dexmedetomidine and midazolam for premedication and emergence delirium in children after dental procedures under general anesthesia: a retrospective study. Drug Des Devel Ther. 2018;12:647–653. doi:10.2147/DDDT.S163828
  • Barends CRM, Absalom A, van Minnen B, Vissink A, Visser A. Dexmedetomidine versus Midazolam in Procedural Sedation. A Systematic Review of Efficacy and Safety. PLoS One. 2017;12(1):e0169525. doi:10.1371/journal.pone.0169525
  • Prabhu M, Mehandale S. Comparison of oral dexmedetomidine versus oral midazolam as premedication to prevent emergence agitation after sevoflurane anaesthesia in paediatric patients. Indian J Anaesth. 2017;61(2):131. doi:10.4103/0019-5049.199852
  • Mason KP, Lubisch NB, Robinson F, Roskos R. Intramuscular Dexmedetomidine Sedation for Pediatric MRI and CT. Am J Roentgenol. 2011;197(3):720–725. doi:10.2214/AJR.10.6134
  • Ruan X. Low-Dose Intramuscular Dexmedetomidine as Premedication: a Randomized Controlled Trial. Med Sci Monit. 2014;20:2714–2719. doi:10.12659/MSM.891051
  • Scheinin H, Jaakola M-L, Sjövall S, et al. Intramuscular Dexmedetomidine as Premedication for General Anesthesia. Anesthesiology. 1993;78(6):1065–1075. doi:10.1097/00000542-199306000-00008
  • Joo E, Kim YJ, Park Y, et al. Intramuscular dexmedetomidine and oral chloral hydrate for pediatric sedation for electroencephalography: a propensity score‐matched analysis. Pediatr Anesth. 2020;30(5):584–591. doi:10.1111/pan.13844
  • Carlone G, Trombetta A, Amoroso S, Poropat F, Barbi E, Cozzi G. Intramuscular Dexmedetomidine, a Feasible Option for Children With Autism Spectrum Disorders Needing Urgent Procedural Sedation. Pediatr Emerg Care. 2019;35(6):e116–e117. doi:10.1097/PEC.0000000000001776
  • Misra S, Behera BK, Mitra JK, Sahoo AK, Jena SS, Srinivasan A. Effect of preoperative dexmedetomidine nebulization on the hemodynamic response to laryngoscopy and intubation: a randomized control trial. Korean J Anesthesiol. 2021;74(2):150–157. doi:10.4097/kja.20153
  • Kumar NR, Jonnavithula N, Padhy S, Sanapala V, Naik V. Evaluation of nebulised dexmedetomidine in blunting haemodynamic response to intubation: a prospective randomised study. Indian J Anaesth. 2020;64(10):874. doi:10.4103/ija.IJA_235_20
  • Zhang H, Sha J, Feng X, et al. Dexmedetomidine ameliorates LPS induced acute lung injury via GSK-3β/STAT3-NF-κB signaling pathway in rats. Int Immunopharmacol. 2019;74:105717. doi:10.1016/j.intimp.2019.105717
  • Meng L, Li L, Lu S, et al. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways. Mol Immunol. 2018;94:7–17. doi:10.1016/j.molimm.2017.12.008
  • Li J, Zhao Y, Zhou N, Li L, Li K. Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress. J Diabetes Res. 2019;2019:1–12.
  • Liang S, Wang Y, Liu Y. Dexmedetomidine alleviates lung ischemia-reperfusion injury in rats by activating PI3K/Akt pathway. Eur Rev Med Pharmacol Sci. 2019;23(1):370–377. doi:10.26355/eurrev_201901_16785
  • Chen Y, Bian W, Xu B. Pretreatment with dexmedetomidine alleviates lung injury in a rat model of intestinal ischemia reperfusion. Mol Med Rep. 2020;21(3):1233–1241. doi:10.3892/mmr.2020.10942
  • Chen Y, Miao L, Yao Y, et al. Dexmedetomidine Ameliorate CLP-Induced Rat Intestinal Injury via Inhibition of Inflammation. Mediators Inflamm. 2015;2015:1–9. doi:10.1155/2015/289519
  • Koca U, Olguner CG, Ergür BU, et al. The effects of dexmedetomidine on secondary acute lung and kidney injuries in the rat model of intra-abdominal sepsis. Sci World J. 2013;2013:1–11.
  • Zhang J-R, Lin Q, Liang F-Q, Xie T. Dexmedetomidine attenuates lung injury by promoting mitochondrial fission and oxygen consumption. Med Sci Monit. 2019;25:1848–1856. doi:10.12659/MSM.913239
  • Sun Y-B, Zhao H, Mu D-L, et al. Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis. Cell Death Dis. 2019;10(3):167. doi:10.1038/s41419-019-1416-5
  • Wu J, Vogel T, Gao X, Lin B, Kulwin C, Chen J. Neuroprotective effect of dexmedetomidine in a murine model of traumatic brain injury. Sci Rep. 2018;8(1):4935. doi:10.1038/s41598-018-23003-3
  • Gao J, Sun Z, Xiao Z, et al. Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury. Br J Anaesth. 2019;123(6):827–838. doi:10.1016/j.bja.2019.08.026
  • Dardalas I, Stamoula E, Rigopoulos P, et al. Dexmedetomidine effects in different experimental sepsis in vivo models. Eur J Pharmacol. 2019;856:172401. doi:10.1016/j.ejphar.2019.05.030
  • Yu Q, Zou L, Yuan X, Fang F, Xu F. Dexmedetomidine protects against septic liver injury by enhancing autophagy through activation of the AMPK/SIRT1 signaling pathway. Front Pharmacol. 2021;12:658677. doi:10.3389/fphar.2021.658677
  • Wang C, Yuan W, Hu A, et al. Dexmedetomidine alleviated sepsis-induced myocardial ferroptosis and septic heart injury. Mol Med Rep. 2020;22(1):175–184. doi:10.3892/mmr.2020.11114
  • Kang K, Gao Y, Wang S-C, et al. Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an α7 nAChR-dependent pathway. Biomed Pharmacother. 2018;106:210–216. doi:10.1016/j.biopha.2018.06.059
  • Shi J, Yu T, Song K, et al. Dexmedetomidine ameliorates endotoxin-induced acute lung injury in vivo and in vitro by preserving mitochondrial dynamic equilibrium through the HIF-1a/HO-1 signaling pathway. Redox Biol. 2021;41:101954. doi:10.1016/j.redox.2021.101954
  • Fu C, Dai X, Yang Y, Lin M, Cai Y, Cai S. Dexmedetomidine attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress, mitochondrial dysfunction and apoptosis in rats. Mol Med Rep. 2017;15(1):131–138. doi:10.3892/mmr.2016.6012
  • Zhang J, Xia F, Zhao H, et al. Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury. PLoS One. 2019;14(7):e0218726. doi:10.1371/journal.pone.0218726
  • Chang J-H, Jin -M-M, Liu J-T. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro. Biomed Pharmacother. 2020;127:110188. doi:10.1016/j.biopha.2020.110188
  • Zhang J, Peng K, Zhang J, Meng X, Ji F. Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway. PLoS One. 2017;12(2):e0172006. doi:10.1371/journal.pone.0172006
  • Yang Y, Wang H, Song N, et al. Dexmedetomidine attenuates ischemia/reperfusion-induced myocardial inflammation and apoptosis through inhibiting endoplasmic reticulum stress signaling. J Inflamm Res. 2021;14:1217–1233. doi:10.2147/JIR.S292263
  • Zhang Y, Gao Q, Wu Z, Xue H, Liu B, Zhao P. Dexmedetomidine promotes hippocampal neurogenesis and improves spatial learning and memory in neonatal rats. Drug Des Devel Ther. 2020;13:4439–4449. doi:10.2147/DDDT.S228220
  • Tachibana K, Hashimoto T, Kato R, et al. Neonatal administration with dexmedetomidine does not impair the rat hippocampal synaptic plasticity later in adulthood. Pediatr Anesth. 2012;22(7):713–719. doi:10.1111/j.1460-9592.2012.03810.x
  • Lv K, Yang C, Xiao R, et al. Dexmedetomidine attenuates ethanol-induced inhibition of hippocampal neurogenesis in neonatal mice. Toxicol Appl Pharmacol. 2020;390:114881. doi:10.1016/j.taap.2020.114881
  • Li J, Chen Q, He X, et al. Dexmedetomidine attenuates lung apoptosis induced by renal ischemia–reperfusion injury through α2AR/PI3K/Akt pathway. J Transl Med. 2018;16(1):78. doi:10.1186/s12967-018-1455-1
  • Yu T, Liu D, Gao M, et al. Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of α7nAChR and PI3K/Akt- mediated autophagy. Biomed Pharmacother. 2019;120:109231. doi:10.1016/j.biopha.2019.109231
  • Elmorsy SA, Soliman GF, Rashed LA, Elgendy H. Dexmedetomidine and propofol sedation requirements in an autistic rat model. Korean J Anesthesiol. 2019;72(2):169–177. doi:10.4097/kja.d.18.00005
  • Chang Y-F, Chao A, Shih P-Y, et al. Comparison of dexmedetomidine versus propofol on hemodynamics in surgical critically ill patients. J Surg Res. 2018;228:194–200. doi:10.1016/j.jss.2018.03.040
  • Jun JH, Kim KN, Kim JY, Song SM. The effects of intranasal dexmedetomidine premedication in children: a systematic review and meta-analysis. Can J Anesth Can D’anesthésie. 2017;64(9):947–961. doi:10.1007/s12630-017-0917-x
  • Yang X, Hu Z, Peng F, et al. Effects of Dexmedetomidine on Emergence Agitation and Recovery Quality Among Children Undergoing Surgery Under General Anesthesia: a Meta-Analysis of Randomized Controlled Trials. Front Pediatr. 2020;8:580226. doi:10.3389/fped.2020.580226
  • Zhu M, Wang H, Zhu A, Niu K, Wang G. Meta-Analysis of Dexmedetomidine on Emergence Agitation and Recovery Profiles in Children after Sevoflurane Anesthesia: different Administration and Different Dosage. PLoS One. 2015;10(4):e0123728. doi:10.1371/journal.pone.0123728
  • Zhang J, Yu Y, Miao S, et al. Effects of peri-operative intravenous administration of dexmedetomidine on emergence agitation after general anesthesia in adults: a meta-analysis of randomized controlled trials. Drug Des Devel Ther. 2019;13:2853–2864. doi:10.2147/DDDT.S207016
  • Vorobeichik L, Brull R, Abdallah FW. Evidence basis for using perineural dexmedetomidine to enhance the quality of brachial plexus nerve blocks: a systematic review and meta-analysis of randomized controlled trials. Br J Anaesth. 2017;118(2):167–181. doi:10.1093/bja/aew411
  • Emelife PI, Eng MR, Menard BL, et al. Adjunct medications for peripheral and neuraxial anesthesia. Best Pract Res Clin Anaesthesiol. 2018;32(2):83–99. doi:10.1016/j.bpa.2018.06.011
  • Trifa M, Tumin D, Tobias JD. Dexmedetomidine as an adjunct for caudal anesthesia and analgesia in children. Minerva Anestesiol. 2018;84(7):836–847. doi:10.23736/S0375-9393.18.12523-5
  • Bielka K, Kuchyn I, Babych V, Martycshenko K, Inozemtsev O. Dexmedetomidine infusion as an analgesic adjuvant during laparoscopic сholecystectomy: a randomized controlled study. BMC Anesthesiol. 2018;18(1):44. doi:10.1186/s12871-018-0508-6
  • Kaye AD, Chernobylsky DJ, Thakur P, et al. Dexmedetomidine in Enhanced Recovery After Surgery (ERAS) Protocols for Postoperative Pain. Curr Pain Headache Rep. 2020;24(5):21. doi:10.1007/s11916-020-00853-z
  • Mao Y, Sun X, Si L, et al. Perioperative Dexmedetomidine Fails to Improve Postoperative Analgesic Consumption and Postoperative Recovery in Patients Undergoing Lateral Thoracotomy for Thoracic Esophageal Cancer: a Randomized, Double-Blind, Placebo-Controlled Trial. Pain Res Manag. 2020;2020:1–12. doi:10.1155/2020/4145893
  • Grape S, Kirkham KR, Frauenknecht J, Albrecht E. Intra‐operative analgesia with remifentanil vs. dexmedetomidine: a systematic review and meta‐analysis with trial sequential analysis. Anaesthesia. 2019;74(6):793–800. doi:10.1111/anae.14657
  • Peng K, Zhang J, Meng X-W, Liu H-Y, Ji F-H. Optimization of Postoperative Intravenous Patient-Controlled Analgesia with Opioid-Dexmedetomidine Combinations: an Updated Meta-Analysis with Trial Sequential Analysis of Randomized Controlled Trials. Pain Physician. 2017;20(7):569–596.
  • Beloeil H, Garot M, Lebuffe G, et al. Balanced Opioid-free Anesthesia with Dexmedetomidine versus Balanced Anesthesia with Remifentanil for Major or Intermediate Noncardiac Surgery. Anesthesiology. 2021;134(4):541–551. doi:10.1097/ALN.0000000000003725
  • Li R, Lai IK, Pan JZ, Zhang P, Maze M. Dexmedetomidine Exerts an Anti-inflammatory Effect via α2 Adrenoceptors to Prevent Lipopolysaccharide-induced Cognitive Decline in Mice. Anesthesiology. 2020;133(2):393–407. doi:10.1097/ALN.0000000000003390
  • Ma J, Chen Q, Li J, et al. Dexmedetomidine-Mediated Prevention of Renal Ischemia-Reperfusion Injury Depends in Part on Cholinergic Anti-Inflammatory Mechanisms. Anesth Analg. 2020;130(4):1054–1062. doi:10.1213/ANE.0000000000003820
  • Chen X, Li L, Hu J, et al. Anti-inflammatory effect of dexmedetomidine combined with hypothermia on acute respiratory distress syndrome in rats. J Surg Res. 2017;216:179–184. doi:10.1016/j.jss.2017.05.014
  • Ueki M, Kawasaki T, Habe K, Hamada K, Kawasaki C, Sata T. The effects of dexmedetomidine on inflammatory mediators after cardiopulmonary bypass. Anaesthesia. 2014;69(7):693–700. doi:10.1111/anae.12636
  • Flanders CA, Rocke AS, Edwardson SA, Baillie JK, Walsh TS. The effect of dexmedetomidine and clonidine on the inflammatory response in critical illness: a systematic review of animal and human studies. Crit Care. 2019;23(1):402. doi:10.1186/s13054-019-2690-4
  • Zhou H, Lu J, Shen Y, Kang S, Zong Y. Effects of dexmedetomidine on CD42a + /CD14 +, HLADR + /CD14 + and inflammatory cytokine levels in patients undergoing multilevel spinal fusion. Clin Neurol Neurosurg. 2017;160:54–58. doi:10.1016/j.clineuro.2017.06.012
  • Xiang H, Hu B, Li Z, Li J. Dexmedetomidine Controls Systemic Cytokine Levels through the Cholinergic Anti-inflammatory Pathway. Inflammation. 2014;37(5):1763–1770. doi:10.1007/s10753-014-9906-1
  • Kim Y, Kang S-H, Hong T-H, et al. Effects of dexmedetomidine on the ratio of T Helper 1 to T Helper 2 cytokines in patients undergoing laparoscopic cholecystectomy. J Clin Anesth. 2014;26(4):281–285. doi:10.1016/j.jclinane.2013.11.018
  • Lee J-M, Han H-J, Choi W-K, Yoo S, Baek S, Lee J. Immunomodulatory effects of intraoperative dexmedetomidine on T helper 1, T helper 2, T helper 17 and regulatory T cells cytokine levels and their balance: a prospective, randomised, double-blind, dose-response clinical study. BMC Anesthesiol. 2018;18(1):164. doi:10.1186/s12871-018-0625-2
  • Qiu Z, Lu P, Wang K, et al. Dexmedetomidine Inhibits Neuroinflammation by Altering Microglial M1/M2 Polarization Through MAPK/ERK Pathway. Neurochem Res. 2020;45(2):345–353. doi:10.1007/s11064-019-02922-1
  • Sun Z, Lin Y, Li Y, et al. The effect of dexmedetomidine on inflammatory inhibition and microglial polarization in BV-2 cells. Neurol Res. 2018;40(10):838–846. doi:10.1080/01616412.2018.1493849
  • Zhang X, Wang J, Qian W, et al. Dexmedetomidine inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated microglia by suppression of extracellular signal-regulated kinase. Neurol Res. 2015;37(3):238–245. doi:10.1179/1743132814Y.0000000426
  • Akeju O, Hobbs LE, Gao L, et al. Dexmedetomidine promotes biomimetic non-rapid eye movement stage 3 sleep in humans: a pilot study. Clin Neurophysiol. 2018;129(1):69–78. doi:10.1016/j.clinph.2017.10.005
  • Huang X, Lin D, Sun Y, Wu A, Wei C. Effect of Dexmedetomidine on Postoperative Sleep Quality: a Systematic Review. Drug Des Devel Ther. 2021;15:2161–2170. doi:10.2147/DDDT.S304162
  • An J-X, Williams JP, Fang Q-W, et al. Feasibility of Patient-Controlled Sleep with Dexmedetomidine in Treating Chronic Intractable Insomnia. Nat Sci Sleep. 2020;12:1033–1042. doi:10.2147/NSS.S262991
  • Bk B, Misra S, Ss J, Cr M. The effect of perioperative dexmedetomidine on postoperative bowel function recovery in adult patients receiving general anaesthesia: a systematic review and meta-analysis of randomised controlled trials. Minerva Anestesiol. 2021. doi:10.23736/S0375-9393.21.15773-6
  • Huang -S-S, Song F-X, Yang S-Z, et al. Impact of intravenous dexmedetomidine on postoperative bowel movement recovery after laparoscopic nephrectomy: a consort-prospective, randomized, controlled trial. World J Clin Cases. 2021;9(26):7762–7771. doi:10.12998/wjcc.v9.i26.7762
  • Xu S-Q, Li Y-H, Wang S-B, Hu S-H, Ju X, Xiao J-B. Effects of intravenous lidocaine, dexmedetomidine and their combination on postoperative pain and bowel function recovery after abdominal hysterectomy. Minerva Anestesiol. 2017;83(7)::685–694. doi:10.23736/S0375-9393.16.11472-5
  • Liu Y, Ai D, Wang X. Efficacy of perioperative intravenous dexmedetomidine administration for the prevention of postoperative sore throat: a meta-analysis. J Int Med Res. 2021;49(5):030006052110176. doi:10.1177/03000605211017686
  • Kuriyama A, Maeda H. Preoperative intravenous dexamethasone prevents tracheal intubation-related sore throat in adult surgical patients: a systematic review and meta-analysis. Can J Anesth Can D’anesthésie. 2019;66(5):562–575. doi:10.1007/s12630-018-01288-2
  • Kim H, Kwon H, Jeon S, Choi EK. The effect of dexmedetomidine and remifentanil on the postoperative sore throat after thyroidectomy. Medicine. 2020;99(29):e21060. doi:10.1097/MD.0000000000021060
  • Thomas D, Chacko L, Raphael P. Dexmedetomidine nebulisation attenuates post-operative sore throat in patients undergoing thyroidectomy: a randomised, double-blind, comparative study with nebulised ketamine. Indian J Anaesth. 2020;64(10):863. doi:10.4103/ija.IJA_406_20
  • Bekker A, Sturaitis MK. Dexmedetomidine for Neurological Surgery. Oper Neurosurg. 2005;57:1–10. doi:10.1227/01.NEU.0000163476.42034.A1
  • Kogan M, McGuire M, Riley J. Deep Brain Stimulation for Parkinson Disease. Neurosurg Clin N Am. 2019;30(2):137–146. doi:10.1016/j.nec.2019.01.001
  • Formolo DA, Gaspar JM, Melo HM, et al. Deep Brain Stimulation for Obesity: a Review and Future Directions. Front Neurosci. 2019;13:323. doi:10.3389/fnins.2019.00323
  • Tierney TS. Deep brain stimulation foundations and future trends. Front Biosci. 2018;23(1):4586. doi:10.2741/4586
  • Husch A, Petersen MV, Gemmar P, Goncalves J, Sunde N, Hertel F. Post-operative deep brain stimulation assessment: automatic data integration and report generation. Brain Stimul. 2018;11(4):863–866. doi:10.1016/j.brs.2018.01.031
  • Lee WH, Park C-K, Park H-P, et al. Effect of Dexmedetomidine Combined Anesthesia on Motor evoked Potentials During Brain Tumor Surgery. World Neurosurg. 2019;123:e280–e287. doi:10.1016/j.wneu.2018.11.152
  • Chen Z, Lin S, Shao W. Effects on somatosensory and motor evoked potentials of senile patients using different doses of dexmedetomidine during spine surgery. Irish J Med Sci. 2015;184(4):813–818. doi:10.1007/s11845-014-1178-0
  • Morace R, De Angelis M, Aglialoro E, et al. Sedation with α2 Agonist Dexmedetomidine During Unilateral Subthalamic Nucleus Deep Brain Stimulation: a Preliminary Report. World Neurosurg. 2016;89:320–328. doi:10.1016/j.wneu.2016.01.037
  • Raimann F, Adam E, Strouhal U, Zacharowski K, Seifert V, Forster M-T. Dexmedetomidine as adjunct in awake craniotomy – improvement or not? Anaesthesiol Intensive Ther. 2020;52(1):15–22. doi:10.5114/ait.2020.93043
  • McAuliffe N, Nicholson S, Rigamonti A, et al. Awake craniotomy using dexmedetomidine and scalp blocks: a retrospective cohort study. Can J Anesth Can D’anesthésie. 2018;65(10):1129–1137. doi:10.1007/s12630-018-1178-z
  • Bano N, Singh P, Singh D, Prabhakar T. A comparative study of midazolam alone or in combination with dexmedetomidine or clonidine for awake fiberoptic intubation. Anesth Essays Res. 2019;13(3):539. doi:10.4103/aer.AER_64_19
  • El Mourad MB, Elghamry MR, Mansour RF, Afandy ME. Comparison of Intravenous Dexmedetomidine-Propofol Versus Ketofol for Sedation During Awake Fiberoptic Intubation: a Prospective, Randomized Study. Anesthesiol Pain Med. 2019;9(1):e86442.
  • Garavaglia MM, Das S, Cusimano MD, et al. Anesthetic Approach to High-Risk Patients and Prolonged Awake Craniotomy Using Dexmedetomidine and Scalp Block. J Neurosurg Anesthesiol. 2014;26(3):226–233. doi:10.1097/ANA.0b013e3182a58aba
  • Mahajan C, Rath G, Singh G, Mishra N, Sokhal S, Bithal P. Efficacy and safety of dexmedetomidine infusion for patients undergoing awake craniotomy: an observational study. Saudi J Anaesth. 2018;12(2):235. doi:10.4103/sja.SJA_608_17
  • Prontera A, Baroni S, Marudi A, et al. Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil. Drug Des Devel Ther. 2017;11:593–598. doi:10.2147/DDDT.S124736
  • Mirkheshti A, Memary E, Honar BN, Jalaeefar A, Sezari P. The efficacy of local dexmedetomidine during fiberoptic nasotracheal intubation: a randomized clinical trial. J Anaesthesiol Clin Pharmacol. 2017;33(2):209–214. doi:10.4103/joacp.JOACP_242_16
  • Dhasmana SC. Nasotracheal Fiberoptic Intubation: patient Comfort, Intubating Conditions and Hemodynamic Stability During Conscious Sedation with Different Doses of Dexmedetomidine. J Maxillofac Oral Surg. 2014;13(1):53–58. doi:10.1007/s12663-012-0469-0
  • Balachundhar S, Puja S, Shahzad S, et al. Effect of Intravenous Acetaminophen vs Placebo Combined With Propofol or Dexmedetomidine on Postoperative Delirium Among Older Patients Following Cardiac Surgery: the DEXACET Randomized Clinical Trial. JAMA. 2019;322(3):276.
  • Sun Y, Liu J, Yuan X, Li Y. Effects of dexmedetomidine on emergence delirium in pediatric cardiac surgery. Minerva Pediatr. 2017;69(3):165–173. doi:10.23736/S0026-4946.16.04227-4
  • Djaiani G, Silverton N, Fedorko L, et al. Dexmedetomidine versus Propofol Sedation Reduces Delirium after Cardiac Surgery. Anesthesiology. 2016;124(2):362–368. doi:10.1097/ALN.0000000000000951
  • Liu X, Xie G, Zhang K, et al. Dexmedetomidine vs propofol sedation reduces delirium in patients after cardiac surgery: a meta-analysis with trial sequential analysis of randomized controlled trials. J Crit Care. 2017;38:190–196. doi:10.1016/j.jcrc.2016.10.026
  • Turan A, Duncan A, Leung S, et al. Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial. Lancet. 2020;396(10245):177–185. doi:10.1016/S0140-6736(20)30631-0
  • Momeni M, Khalifa C, Lemaire G, et al. Propofol plus low-dose dexmedetomidine infusion and postoperative delirium in older patients undergoing cardiac surgery. Br J Anaesth. 2021;126(3):665–673. doi:10.1016/j.bja.2020.10.041
  • Tang Y, Yang M, Fu F, Huang X, Feng Y, Chen X. Comparison of the ED50 of intrathecal hyperbaric ropivacaine co-administered with or without intrathecal dexmedetomidine for cesarean section: a prospective, double-blinded, randomized dose-response trial using up-down sequential allocation method. J Clin Anesth. 2020;62:109725. doi:10.1016/j.jclinane.2020.109725
  • Liu L, Qian J, Shen B, Xiao F, Shen H. Intrathecal dexmedetomidine can decrease the 95% effective dose of bupivacaine in spinal anesthesia for cesarean section. Medicine. 2019;98(9):e14666. doi:10.1097/MD.0000000000014666
  • Nasseri K, Ghadami N, Nouri B. Effects of intrathecal dexmedetomidine on shivering after spinal anesthesia for cesarean section: a double-blind randomized clinical trial. Drug Des Devel Ther. 2017;11:1107–1113. doi:10.2147/DDDT.S131866
  • Zhang Q, Wang L, Xu M, Wang T. Protective effect of dexmedetomidine on kidney injury of parturients with preeclampsia undergoing cesarean section: a randomized controlled study. Biosci Rep. 2019;39:5.
  • Yu Z, Zhang P, Wang H, et al. Effects of dexmedetomidine versus remifentanil on mothers and neonates during cesarean section under general anesthesia. Biomed Pap. 2020;164(4):417–424. doi:10.5507/bp.2019.055
  • Wang Y, Fang X, Liu C, Ma X, Song Y, Yan M. Impact of Intraoperative Infusion and Postoperative PCIA of Dexmedetomidine on Early Breastfeeding After Elective Cesarean Section: a Randomized Double-Blind Controlled Trial. Drug Des Devel Ther. 2020;14:1083–1093. doi:10.2147/DDDT.S241153
  • Pérez-González O, Cuéllar-Guzmán LF, Soliz J, Cata JP. Impact of Regional Anesthesia on Recurrence, Metastasis, and Immune Response in Breast Cancer Surgery. Reg Anesth Pain Med. 2017;42(6):751–756. doi:10.1097/AAP.0000000000000662
  • Sessler DI, Riedel B. Anesthesia and Cancer Recurrence. Anesthesiology. 2019;130(1):3–5. doi:10.1097/ALN.0000000000002506
  • Rivero EM, Martinez LM, Bruque CD, Gargiulo L, Bruzzone A, Lüthy IA. Prognostic significance of α‐ and β2‐adrenoceptor gene expression in breast cancer patients. Br J Clin Pharmacol. 2019;85(9):2143–2154. doi:10.1111/bcp.14030
  • Liu Y, Sun J, Wu T, et al. Effects of serum from breast cancer surgery patients receiving perioperative dexmedetomidine on breast cancer cell malignancy: a prospective randomized controlled trial. Cancer Med. 2019;8(18):7603–7612. doi:10.1002/cam4.2654
  • Lamkin DM, Sung HY, Yang GS, et al. α2-Adrenergic blockade mimics the enhancing effect of chronic stress on breast cancer progression. Psychoneuroendocrinology. 2015;51:262–270. doi:10.1016/j.psyneuen.2014.10.004
  • Yi X-L, Wang J-T, Chu C-Q, Li Y-X, Yin J-H, Liu S-L. Cardiocerebral protective effects of dexmedetomidine as anesthetic in colorectal cancer surgery. Eur Rev Med Pharmacol Sci. 2018;22(11):3570–3576. doi:10.26355/eurrev_201806_15183
  • Hetta D, Fares KM, Abedalmohsen AM, Abdel-Wahab AH, Abo Elfadl GM, Ali WN. Epidural dexmedetomidine infusion for perioperative analgesia in patients undergoing abdominal cancer surgery: randomized trial. J Pain Res. 2018;11:2675–2685. doi:10.2147/JPR.S163975
  • Huang L, Qin C, Wang L, Zhang T, Li J. Effects of dexmedetomidine on immune response in patients undergoing radical and reconstructive surgery for oral cancer. Oncol Lett. 2020;21(2):106. doi:10.3892/ol.2020.12367
  • Wang Z, Shen Z, Wang H, Zhang L, Dong R. Effect of dexmedetomidine on the cognitive function of patients undergoing gastric cancer surgery by regulating the PI3K/AKT signaling pathway. Oncol Lett. 2020;19(2):1151–1156. doi:10.3892/ol.2019.11224
  • Fares KM, Mohamed SA-B, Abd El-Rahman AM, AbdeLemam RM, Osman AMM. Analgesic effect of intrathecal fentanyl vs dexmedetomidine as adjuvants to bupivacaine following abdominal surgery for cancer in children, a randomized trial. Pain Med. 2020;21(11):2634–2641. doi:10.1093/pm/pnaa259
  • Gautam B, Tabdar S, Shrestha U. Comparison of fentanyl and dexmedetomidine as intrathecal adjuvants to spinal anaesthesia for abdominal hysterectomy. JNMA J Nepal Med Assoc. 2018;56(213):848–855. doi:10.31729/jnma.3739
  • Sun S, Wang J, Bao N, Chen Y, Wang J. Comparison of dexmedetomidine and fentanyl as local anesthetic adjuvants in spinal anesthesia: a systematic review and meta-analysis of randomized controlled trials. Drug Des Devel Ther. 2017;11:3413–3424. doi:10.2147/DDDT.S146092
  • Li C, Li Y, Wang K, Kong X. Comparative evaluation of remifentanil and dexmedetomidine in general anesthesia for cesarean delivery. Med Sci Monit. 2015;21:3806–3813. doi:10.12659/MSM.895209
  • Shin H-J, Do S-H, Lee J-S, Kim T-K, Na H-S. Comparison of intraoperative sedation with dexmedetomidine versus propofol on acute postoperative pain in total knee arthroplasty under spinal anesthesia. Anesth Analg. 2019;129(6):1512–1518. doi:10.1213/ANE.0000000000003315
  • Venkatraghavan L, Luciano M, Manninen P. Anesthetic management of patients undergoing deep brain stimulator insertion. Anesth Analg. 2010;1:587.
  • Grant R, Gruenbaum SE, Gerrard J. Anaesthesia for deep brain stimulation. Curr Opin Anaesthesiol. 2015;28(5):505–510. doi:10.1097/ACO.0000000000000230
  • Guldenmund P, Vanhaudenhuyse A, Sanders RD, et al. Brain functional connectivity differentiates dexmedetomidine from propofol and natural sleep. Br J Anaesth. 2017;119(4):674–684. doi:10.1093/bja/aex257
  • Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306. doi:10.1097/CCM.0b013e3182783b72